Tue, June 20, 2023

Edwin Zhang Initiated (CALT) at Strong Buy and Held Target at $60 on, Jun 20th, 2023

Edwin Zhang of HC Wainwright & Co., Initiated "Calliditas Therapeutics AB (publ)" (CALT) at Strong Buy and Held Target at $60 on, Jun 20th, 2023.

Edwin has made no other calls on CALT in the last 4 months.



There are 2 other peers that have a rating on CALT. Out of the 2 peers that are also analyzing CALT, 1 agrees with Edwin's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Vamil Divan of "Guggenheim" Initiated at Hold and Held Target at $18 on, Wednesday, March 1st, 2023


This is the rating of the analyst that currently disagrees with Edwin


  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $79 on, Friday, February 24th, 2023